# Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

> **NCT06894576** · — · RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer-associated Thrombosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06894576
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-03
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06894576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06894576, "Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06894576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*